Stuttgart - Delayed Quote EUR

Novozymes A/S (NZM2.SG)

Compare
54.36 +0.58 (+1.08%)
At close: December 20 at 4:48:10 PM GMT+1
Currency in DKK All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
17,899,000.00
17,899,000.00
17,553,000.00
14,951,000.00
14,012,000.00
Cost of Revenue
8,177,000.00
8,177,000.00
7,976,000.00
6,328,000.00
6,159,000.00
Gross Profit
9,722,000.00
9,722,000.00
9,577,000.00
8,623,000.00
7,853,000.00
Operating Expense
5,258,000.00
5,258,000.00
5,149,000.00
4,738,000.00
4,243,000.00
Operating Income
4,464,000.00
4,464,000.00
4,428,000.00
3,885,000.00
3,610,000.00
Net Non Operating Interest Income Expense
-149,000.00
-149,000.00
-183,000.00
-104,000.00
-84,000.00
Pretax Income
3,909,000.00
3,909,000.00
4,556,000.00
3,924,000.00
3,521,000.00
Tax Provision
870,000.00
870,000.00
870,000.00
779,000.00
695,000.00
Net Income Common Stockholders
3,024,000.00
3,024,000.00
3,676,000.00
3,146,000.00
2,825,000.00
Diluted NI Available to Com Stockholders
3,024,000.00
3,024,000.00
3,676,000.00
3,146,000.00
2,825,000.00
Basic EPS
10.92
10.92
13.29
11.32
10.07
Diluted EPS
10.88
10.88
13.19
11.23
10.02
Basic Average Shares
277,035.07
277,035.07
276,644.15
277,919.16
280,427.91
Diluted Average Shares
277,874.97
277,874.97
278,733.92
280,228.11
282,023.41
Total Operating Income as Reported
4,552,000.00
4,552,000.00
4,629,000.00
4,007,000.00
3,652,000.00
Total Expenses
13,435,000.00
13,435,000.00
13,125,000.00
11,066,000.00
10,402,000.00
Net Income from Continuing & Discontinued Operation
3,024,000.00
3,024,000.00
3,676,000.00
3,146,000.00
2,825,000.00
Normalized Income
3,313,044.00
3,313,044.00
3,406,603.00
2,949,755.00
2,784,850.00
Interest Income
90,000.00
90,000.00
18,000.00
18,000.00
10,000.00
Interest Expense
173,000.00
173,000.00
102,000.00
102,000.00
63,000.00
Net Interest Income
-149,000.00
-149,000.00
-183,000.00
-104,000.00
-84,000.00
EBIT
4,082,000.00
4,082,000.00
4,658,000.00
4,026,000.00
3,584,000.00
EBITDA
5,471,000.00
5,471,000.00
6,115,000.00
5,400,000.00
4,850,000.00
Reconciled Cost of Revenue
8,177,000.00
8,177,000.00
7,976,000.00
6,328,000.00
6,159,000.00
Reconciled Depreciation
1,389,000.00
1,389,000.00
1,457,000.00
1,374,000.00
1,266,000.00
Net Income from Continuing Operation Net Minority Interest
3,024,000.00
3,024,000.00
3,676,000.00
3,146,000.00
2,825,000.00
Total Unusual Items Excluding Goodwill
-372,000.00
-372,000.00
333,000.00
245,000.00
50,000.00
Total Unusual Items
-372,000.00
-372,000.00
333,000.00
245,000.00
50,000.00
Normalized EBITDA
5,843,000.00
5,843,000.00
5,782,000.00
5,155,000.00
4,800,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-82,956.00
-82,956.00
63,603.00
48,755.00
9,850.00
12/31/2020 - 12/28/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade